PDS BIOTECHNOLOGY CORP (PDSB)

US70465T1079 - Common Stock

3.53  +0.03 (+0.86%)

After market: 3.64 +0.11 (+3.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
56.56M73.80M65.20M28.80M12.20M
Receivables
N/AN/AN/AN/AN/A
Other Current Assets
2.49M2.70M1.60M1.50M2.30M
Total Current Assets
59.06M76.50M66.80M30.30M14.50M
 
Non-Current Assets
PPE Net
335.01K500.00K400.00K600.00K0.00
Other Non-Current Assets
N/AN/AN/AN/A0.00
Total Non-Current Assets
335.00K500.00K400.00K600.00K0.00
 
TOTAL ASSETS
59.39M77.00M67.20M30.90M14.50M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
4.22M100.00KN/AN/AN/A
Accrued Expenses
2.42M8.50M2.40M1.90M1.10M
Accounts Payable
6.98M1.20M1.30M1.40M1.20M
Other Current Liabilities
N/AN/AN/A0.00500.00K
Total Current Liabilities
13.63M9.80M3.80M3.30M2.80M
 
Non-Current Liabilities
Long Term Debt
19.63M23.20M0.000.000.00
Other Non-Current Liabilities
0.000.00200.00K500.00K0.00
Total Non-Current Liabilities
19.63M23.20M200.00K500.00K0.00
 
TOTAL LIABILITIES
33.26M33.00M4.00M3.80M2.80M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-144.50M-101.60M-60.70M-43.80M-28.90M
Additional Paid In Capital
170.62M145.60M123.90M70.90M40.60M
Common Shares
10.92K0.000.000.000.00
Shares Outstanding
33.09M30.20M28.40M22.30M5.30M
Tangible Book Value per Share
0.791.462.231.222.21
Total Shareholders' Equity
26.13M44.00M63.20M27.10M11.70M
 
TOTAL LIABILITIES AND EQUITY
59.39M77.00M67.20M30.90M14.50M
 
Statistics
Debt/Equity
0.750.53N/AN/AN/A
Current Ratio
4.337.8117.589.185.18
Return On Assets (ROA)
-72.31%-53.05%-25.18%-48.06%-48.28%
Return On Equity (ROE)
-164.33%-92.84%-26.77%-54.80%-59.83%

All data in USD

Charts